TP53 and squamous cell carcinoma: ING5 has been described as a tumor suppressor since it was both mutated and down regulated in squamous cell carcinoma [47], inhibited EMT and invasion in lung cancers [48] by targeting the WNT/b-catenin pathway [21] and regulates p53 activity by acetylation [15,49].